Latest Breaking News On - ஜெநெடிக் நோய் - Page 1 : comparemela.com

Global Molecular Cytogenetics Markets 2021-2027: Northbound Trajectory in Med Tech Sector to Generate Parallel Opportunities

Global Molecular Cytogenetics Markets 2021-2027: Northbound Trajectory in Med Tech Sector to Generate Parallel Opportunities
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

AustraliaJapanUnited statesUnited kingdomArgentinaBrazilChinaCanadaRussiaMexicoGermanyIndiaIsraelItalySaudi arabiaSouth korea

When your heart's too thick to work well

Hypertrophic cardiomyopathy is a genetic heart disease that occurs in one in 500 people. People with this condition have an abnormal arrangement of heart muscle cells, which is usually caused by gene mutations that make the heart grow abnormally thick. This makes it more difficult for the heart to pump blood. In some cases, those with the condition might not even be aware that they have it. Mayo Clinic cardiologist Dr Steve Ommen, who specialises in this disease, says that shortness of breath or chest pain, especially during exercise, are common symptoms. “It’s important to first point out that it’s completely compatible with a normal life span and a normal quality of life,” he says.

Steve ommenMayo clinic news network tribune serviceMayo clinic newsTribune newsHeart diseaseNon communicable diseasesGenetic diseaseமயோ சிகிச்சையகம் செய்தி வலைப்பின்னல் ட்ரிப்யூன் சேவைமயோ சிகிச்சையகம் செய்திட்ரிப்யூன் செய்திஇதயம் நோய்அல்லாத தொடர்பு கொள்ளக்கூடியது நோய்கள்ஜெநெடிக் நோய்

Global Genetic Testing Market Report 2021-2025: Explosion in Genetic Knowledge Creates New Global Market for Diagnostics

Global Genetic Testing Market Report 2021-2025: Explosion in Genetic Knowledge Creates New Global Market for Diagnostics
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

ChinaAustraliaUnited statesChineseAmericaLaura woodProfiles of key companiesInvitae acquires three companiesConsortium developing genetic test for immunologicPublic nationalCentral labUs medicare expenditures for laboratory testingTechnology developmentThermo fisherSelf testing disruptiveYourgene health to acquire elucigene

Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities

Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities March 12, 2021 05:03 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com s offering. The Global Precision Medicine Market is estimated to be USD 53.5 Bn in 2020 and is expected to reach USD 92.2 Bn by 2025 growing at a CAGR of 11.5%. The factors such as patient s involvement in personal healthcare, development of technologies such as sequencing technologies, increasing genetic diseases, the growing demand for targeted therapies, and integration of big data healthcare companies with pharma & biotech companies are driving the market growth. The increasing population and rising cancer cases in developing countries in the APAC region like India and China are the major factors propelling the growth of the precision medicine market. The current soaring prices of drug discovery along with the increasi

MexicoGermanyAustraliaJapanUnited statesIndiaUnited kingdomArgentinaBrazilChinaItalyCanadaDublinIrelandFranceAmerica

Genetic Testing Market revenue to cross USD 31.8 Bn by 2027: Global Market Insights Inc.

According to latest report “Genetic Testing Market by Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), Application (Cancer, Genetic Disease, Cardiovascular Disease), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027”, by Global Market Insights Inc., the market valuation of genetic testing will cross $31.8 billion by 2027. Availability of different genetic tests across the globe for early and accurate disease diagnosis will enhance the market growth during the forecast timeline. Direct-to-consumer genetic tests provides access to genetic information of the customers without necessarily involving any health insurance company or a healthcare provider in the process. DTC tests enable customers to identify a genetic predisposition to various diseases such as diabetes, cancer and Alzheimer’s. In addition, some DTC genetic tests are used for prediction of potent

GermanyDelawareUnited statesSelbyvilleUnited kingdomFranceAsia pacificGlobal market insights incHelix coCepheid danaher corporationBiocartis groupAbbott laboratoriesMe inc ltdTesting marketTest typePredictive testing